After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year
https://www.cnn.com/2022/11/01/health/rsv-vaccine-pfizer-fda
Pfizer says it has enough promising data on its respiratory syncytial virus, or RSV, vaccine designed to protect newborns that it will end enrollment in the study and submit for US Food and Drug Administration approval by the end of the year.
RSV is a common respiratory virus that typically causes mild, cold-like symptoms, but it can cause serious illness, particularly in older adults and infants. Pfizer’s vaccine candidate is administered to pregnant women who then make antibodies that cross the placenta and protect the baby after birth.
PS
所有跟帖:
• 妈打了新冠疫苗也会传导给婴幼儿。 -枫林晓- ♂ (0 bytes) () 11/19/2022 postreply 08:02:25
• 俺儿媳妇在喂奶期得了新冠,婴孩还是喝母奶。居然没染上新冠。不知是还在六个月龄内的关系还是母乳含有抗体? -老子说两句- ♂ (0 bytes) () 11/19/2022 postreply 09:19:59